ArticleInternational journal of molecular sciences2025
Degenerative Disease Diagnosis and Analysis Based on Tissue Specificity of DNA Methylation.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanisms and therapeutic prospects of DNA methylation-mucosal innate immunity crosstalk in inflammatory bowel disease.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The tissue specificity of DNA methylation refers to the significant differences in DNA methylation patterns in different tissues. This specificity regulates gene expression, thereby supporting the specific functions of each tissue and the maintenance of normal physiological activities. Abnormal tissue-specific patterns of DNA methylation are closely related to age-related diseases. This abnormal methylation pattern affects the regulation of gene expression, which may lead to changes in cell function and promote the occurrence of pathological conditions. By analyzing the differences in these methylation patterns, key CpG sites for disease diagnosis can be effectively screened. The main goal of this paper is to use the characteristics associated with tissue-specific abnormal expression and disease to construct an age-related disease diagnosis model. First, we combined chi-square tests and logistic regression to identify tissue-specific and disease-specific CpG sites, laying the foundation for accurate medical diagnosis, and verified the biological relevance of these CpG sites through enrichment analysis. Then we used the Transformer model to fit these CpG sites and realized the automatic diagnosis of age-related diseases. Our work proves that the tissue specificity of DNA methylation has the potential to diagnose age-related diseases, and proves the scientific nature of our proposed diagnostic method from a biological perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.